Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Organogenesis Holdings (ORGO) Leases (2017 - 2026)

Organogenesis Holdings has reported Leases over the past 9 years, most recently at $55.7 million for Q4 2025.

  • For Q4 2025, Leases rose 50.23% year-over-year to $55.7 million; the TTM value through Dec 2025 reached $55.7 million, up 50.23%, while the annual FY2025 figure was $55.7 million, 50.23% up from the prior year.
  • Leases for Q4 2025 was $55.7 million at Organogenesis Holdings, up from $33.3 million in the prior quarter.
  • Over five years, Leases peaked at $55.7 million in Q4 2025 and troughed at $2.1 million in Q2 2023.
  • A 5-year average of $37.1 million and a median of $37.9 million in 2024 define the central range for Leases.
  • Biggest five-year swings in Leases: tumbled 95.41% in 2023 and later soared 1636.56% in 2024.
  • Year by year, Leases stood at $49.1 million in 2021, then dropped by 12.11% to $43.2 million in 2022, then fell by 7.12% to $40.1 million in 2023, then decreased by 7.5% to $37.1 million in 2024, then soared by 50.23% to $55.7 million in 2025.
  • Business Quant data shows Leases for ORGO at $55.7 million in Q4 2025, $33.3 million in Q3 2025, and $35.3 million in Q2 2025.